Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet injury during phototherapy

H M Maurer, J C Haggins, W J Still

    American Journal of Hematology
    |January 1, 1976
    PubMed
    Summary

    Blue light phototherapy, used for neonatal jaundice, damages human platelets. This light exposure impairs platelet function and causes structural changes, indicating potential risks beyond treating hyperbilirubinemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.

    Sarcoma·2008
    Same author

    Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

    Journal of pediatric hematology/oncology·2002
    Same author

    Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.

    Journal of pediatric hematology/oncology·2002
    Same author

    Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?

    Seminars in pediatric surgery·2001
    Same author

    What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?

    Cancer·2001

    Area of Science:

    • Biomedical Science
    • Hematology
    • Photobiology

    Background:

    • Phototherapy is a standard treatment for neonatal hyperbilirubinemia.
    • The effects of phototherapy on neonatal physiology are well-studied.
    • Potential side effects on cellular components require investigation.

    Purpose of the Study:

    • To investigate the effects of blue light phototherapy on human platelets.
    • To characterize functional, biochemical, and morphological changes in platelets.
    • To assess the impact of light exposure duration and photosensitizers.

    Main Methods:

    • Human platelet-rich plasma was exposed to blue fluorescent light.
    • Light exposure mimicked clinical phototherapy conditions.
    • Platelet aggregation, biochemical assays (ADP, ATP, glycogen), and electron microscopy were performed.

    Main Results:

    • Platelets lost aggregability and depleted ADP, ATP, and glycogen within 110 minutes of light exposure.
    • Electron microscopy showed platelet swelling, organelle depletion, and membrane damage.
    • Photosensitizers like hematoporphyrin accelerated platelet injury.

    Conclusions:

    • Blue light phototherapy causes significant in vitro damage to human platelets.
    • Platelet dysfunction and structural alterations occur with clinically relevant light exposure.
    • Further research is needed to understand the clinical implications of these findings.

    Related Experiment Videos